Engineered immune cells battle childhood cancer in groundbreaking trial
NCT ID NCT04787263
Summary
This study tests a personalized treatment called CAR-T cell therapy for children and young adults whose B-cell blood cancers have returned or resisted standard treatments. Doctors collect a patient's own immune cells, modify them in a lab to better target cancer cells, and then infuse them back into the body. The trial first aims to find a safe dose and then tests how well this approach works against leukemia and lymphoma.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IRCCS Ospedale Pediatrico Bambino Gesù
Roma, 00165, Italy
Conditions
Explore the condition pages connected to this study.